Utama › Kanser Prostat › California › Mountain View
Kajian klinikal Kanser Prostat di Mountain View, CA
15 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Mountain View (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Mengambil pesertaFasa 3
- Stanford Cancer Center ( Site 0036), Palo Alto · 5 mi jauh
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Mengambil pesertaFasa 2/3
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauh
- Stanford University Medical Center, Palo Alto · 5 mi jauh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
- Stanford University Medical Center, Stanford · 5 mi jauh
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Mengambil pesertaFasa 3
- Stanford University Medical Center, Palo Alto · 5 mi jauh
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- Stanford Cancer Center ( Site 0046), Palo Alto · 5 mi jauh
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Mengambil peserta
- USNC, Mountain View
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Mengambil pesertaFasa 3
- Stanford University Medical Center, Stanford · 5 mi jauh
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Mengambil pesertaFasa 1
- Investigational Site Number: 403, Palo Alto · 5 mi jauh
Prostate Active Surveillance Study
Mengambil pesertaKajian pemerhatian
- Stanford University, Stanford · 5 mi jauh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi jauh
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Mengambil pesertaFasa 1
- Stanford Cancer Center, Palo Alto · 5 mi jauh
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauh
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauh
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Research Site, Palo Alto · 5 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauh
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauh
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Mountain View
- Kanser (semua jenis)40 kajian
- Kanser Payudara25 kajian
- Kanser Metastatik25 kajian
- Kanser Paru-paru Bukan Sel Kecil21 kajian
- Leukemia Mieloid Akut19 kajian
- Kanser Ovari19 kajian
- Gangguan Spektrum Autisme17 kajian
- Kanser Paru-paru17 kajian
- Kegagalan Jantung15 kajian
- Autisme13 kajian
- Leukemia Limfoblastik Akut13 kajian
- Kanser Kolorektal13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.